Literature DB >> 27650234

Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis.

Jiancheng Zhao1, Xingshun Qi2, Feifei Hou1, Zheng Ning3, Xintong Zhang4, Han Deng3, Ying Peng3, Jing Li3, Xiaoxi Wang1, Hongyu Li5, Xiaozhong Guo6.   

Abstract

BACKGROUND: QTc interval prolongation is an electrocardiographic abnormality in liver cirrhosis. The objective of this study was to evaluate the prevalence, risk factors and in-hospital outcomes of QTc interval prolongation in Chinese patients with liver cirrhosis.
METHODS: This was a retrospective analysis of a total of 1,268 patients with liver cirrhosis who were consecutively admitted to our hospital between January 2011 and June 2014. QTc interval data were collected from the medical records. QTc interval prolongation was defined as QTc interval > 440 milliseconds.
RESULTS: The prevalence of QTc interval prolongation was 38.2% (485 of 1268). In the entire cohort, the risk factors for QTc interval prolongation included an older age, a higher proportion of alcohol abuse and ascites, higher bilirubin, blood urea nitrogen, creatinine, prothrombin time, international normalized ratio, Child-Pugh score and model for end-stage liver diseases score, and lower red blood cell (RBC), hemoglobin (Hb), albumin (ALB), alanine aminotransferase and calcium. The in-hospital mortality was not significantly different between patients with and without QTc interval prolongation (2.1% versus 1.3%, P = 0.276). In the subgroup analyses of patients with hepatitis B virus or alcohol alone-related liver cirrhosis, the risk factors included higher bilirubin, creatinine, prothrombin time, international normalized ratio, Child-Pugh score and model for end-stage liver diseases score, and lower RBC, Hb and ALB. In the subgroups analyses of patients with acute upper gastrointestinal bleeding or ascites, the risk factors included lower RBC, Hb and ALB.
CONCLUSIONS: QTc interval prolongation was frequent in liver cirrhosis. Although QTc interval prolongation was positively associated with alcohol-related liver cirrhosis and more severe liver dysfunction, it did not significantly influence the in-hospital mortality.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Liver cirrhosis; Prognosis; QTc interval; Risk factor

Mesh:

Substances:

Year:  2016        PMID: 27650234     DOI: 10.1016/j.amjms.2016.06.012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications).

Authors:  Luis Téllez; Antonio Guerrero
Journal:  Clin Drug Investig       Date:  2022-05-06       Impact factor: 3.580

Review 2.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 3.  What Every Intensivist should Know about Impairment of Cardiac Function and Arrhythmias in Liver Disease Patients: A Review.

Authors:  Sanjeev Arya; Prashant Kumar; Bhuwan Tiwari; Shantanu Belwal; Sanjay Saxena; Haider Abbas
Journal:  Indian J Crit Care Med       Date:  2020-12

4.  QTc interval prolongation in the patients with primary biliary cholangitis.

Authors:  Zihao Wang; Rongkai Qian; Yanhua Wang; Lingfei Mo; Bomiao Ju; Nan Hu; Pei Wang; Lan He; Jing Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-02       Impact factor: 1.468

5.  Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity.

Authors:  Elias Tsiompanidis; Spyros I Siakavellas; Anastasios Tentolouris; Ioanna Eleftheriadou; Stamatia Chorepsima; Anastasios Manolakis; Konstantinos Oikonomou; Nikolaos Tentolouris
Journal:  World J Gastrointest Pathophysiol       Date:  2018-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.